Process For The Synthesis Of The 7,8-Dimethoxy-1,3-Dihydro-2H-3-Benzazepin-2-One, And Its Application To The Synthesis Of Ivabradine As Well As Its Addition Salts With A Pharmaceutically Acceptable Acid

Patent No. EP2135861 (titled "Process For The Synthesis Of The 7,8-Dimethoxy-1,3-Dihydro-2H-3-Benzazepin-2-One, And Its Application To The Synthesis Of Ivabradine As Well As Its Addition Salts With A Pharmaceutically Acceptable Acid") was filed by LES LABORATOIRES SERVIER on Jun 19, 2009. The application was issued on Dec 16, 2020.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UK TRADING MYLANApr 30, 2015GILANI

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2135861

LES LABORATOIRES SERVIER
Application Number
EP09290466A
Filing Date
Jun 19, 2009
Status
Patent Maintained As Amended
Nov 13, 2020
Publication Date
Dec 16, 2020